Medicare Aims to Expand Coverage of Cancer Care. But Is It Enough?
Doctors and patients are pushing the Trump administration to pay for a powerful but costly cancer treatment known as CAR-T, one of many new “ personalized medicines. ”
Source: NYT Health - Category: Consumer Health News Authors: ROBERT PEAR Tags: Health Insurance and Managed Care Drugs (Pharmaceuticals) Medicare Immunotherapy Cancer Centers for Medicare and Medicaid Services Hospitals Source Type: news
More News: American Health | Cancer | Cancer & Oncology | Centers for Medicare and Medicaid Services (CMS) | Health | Health Insurance | Hospitals | Immunotherapy | Insurance | Managed Care | Medicaid | Medicare | Trump | USA Health